Top-Analysts PicksInvest alongside the top 15% of Wall Street analysts.

Try Top-Picks
ORIC Pharmaceuticals, Inc. Banner

ORIC Pharmaceuticals, Inc.

ORIC Stock Analysis

Page title

Section title

Breakdown
2017
2018
2019
2020
2021
2022
2023
Net Income
-22.029m-21.363m-26.883m-73.703m-78.715m-89.122m-100.697m
Depreciation & Amortization
900.000K903.000K1.028M970.000K897.000K966.000K1.032M
Change in Working Capital
95.000K-707.000k1.220M2.045M4.073M-445.000k4.898M
Operating Cash Flow
-20.832m-20.683m-23.533m-45.268m-59.541m-75.143m-85.915m
Capital Expenditure
-486.000k-525.000k-768.000k-667.000k-939.000k-2.078m-849.000k
Free Cash Flow
-21.318m-21.208m-24.301m-45.935m-60.480m-77.221m-86.764m
Debt Repayment
0.0000.0000.0000.0000.0000.0000.000
Dividends Paid
0.0000.0000.0000.0000.0000.0000.000
Common Stock Issued
260.000K38.008M70.923M271.308M50.000M25.624M85.885M
Common Stock Repurchased
0.0000.0000.0000.0000.000545.000K0.000
Net Change in Cash
-20.864m16.817M46.523M-10.713m148.028M-159.166m-43.456m